Next-gen gene editing, Keith Gottesdiener, President & CEO, Jeremy Duffield, CSO, Prime Medicine
22 Nov 2023
40m
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.
